Literature DB >> 4475611

Correlation of 5-fluorouracil (NSC-19893) distribution in rodents with toxicity and chemotherapy in man.

R H Liss, M Chadwick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4475611

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  9 in total

1.  The clinical syndrome of 5-fluorouracil cardiotoxicity.

Authors:  J F Ensley; B Patel; R Kloner; J A Kish; J Wynne; M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 2.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

3.  Acute myocardiotoxicity during 5-fluorouracil therapy.

Authors:  B Misset; B Escudier; B Leclercq; D Rivara; P Rougier; G Nitenberg
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

4.  Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose.

Authors:  G W Visser; G C Gorree; G J Peters; J D Herscheid
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 5.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Cardiopulmonary hemodynamics and pharmacokinetics after hepatic intraarterial infusion of 5-fluorouracil (5-FU). An experimental study in the pig.

Authors:  M Andersson; L Domellöf; S Häggmark; G Johansson; S Reiz; B Gustavsson
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.

Authors:  G J Peters; J Lankelma; R M Kok; P Noordhuis; C J van Groeningen; C L van der Wilt; S Meyer; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.

Authors:  C H Köhne; P Thuss-Patience; M Friedrich; P T Daniel; A Kretzschmar; T Benter; B Bauer; R Dietz; B Dörken
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

9.  In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.

Authors:  R S Camplejohn; B Schultze; W Maurer
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.